Systemic Allergic Reactions to Subcutaneous Allergen Immunotherapy—A Single-Center Experience
Our findings confirm that SRs to SCIT are rare, and severe reactions are infrequent. A higher serum sIgE/tIgE ratio can be risk factor for severe SRs. Nonetheless, a thorough risk-benefit assessment is essential prior to initiating SCIT, particularly in patients with identified risk factors.
Authors
- Aleksandra Plavšić (ORCID: https://orcid.org/0000-0002-0393-0874)
- Jasna Bolpačić (ORCID: https://orcid.org/0000-0001-7115-8081)
- Vesna Tomić-Spirić (ORCID: https://orcid.org/0000-0002-7047-3538)
- Nataša Kusić (ORCID: https://orcid.org/0009-0003-9727-7128)
- Irena Ostric (ORCID: https://orcid.org/0000-0003-0944-9675)
- Rajica Stošović (ORCID: https://orcid.org/0000-0002-3815-5644)
- Vedrana Đurić
- M.R. Dimitrijević (ORCID: https://orcid.org/0009-0001-3358-1249)
- Antonije Veličković
- Jelena Spirić-Milovančević
Institutions
- University of Belgrade (RS)
Publication Details
- Journal
- Life
- Published
- 2025-09-28
- DOI
- https://doi.org/10.3390/life15101527
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00